Skip to main content

A broken window of the vehicle that was carrying Tetsu Nakamura shows the after-effects of the attack.

PARWIZ/Reuters

Gunmen killed six people, including the head of a Japanese aid agency, on Wednesday in an attack on their vehicle in Jalalabad, eastern Afghanistan, officials said.

The ambush comes a week after a grenade attack on a United Nations vehicle in Kabul heightened fears for those doing humanitarian work amid one of the world’s longest-running conflicts.

Tetsu Nakamura, head of Peace Japan Medical Services, had been involved in rebuilding Afghan irrigation and agriculture, and had recently been granted honourary Afghan citizenship for decades of humanitarian work in the east of the country.

Story continues below advertisement

“I am shocked that he had to die in this way,” Japanese Prime Minister Shinzo Abe told a news conference in Tokyo.

“He risked his life in a dangerous environment to do various work, and the people of Afghanistan were very grateful to him,” Mr. Abe added.

The gunmen fled the scene and police have launched a search operation to arrest them, Sohrab Qaderi, a member of the governing council in the province of Nangarhar told Reuters, adding that he believed Dr. Nakamura had been targeted for his work.

“Dr. Nakamura has been doing great work in the reconstruction of Afghanistan, especially in irrigation and agriculture,” he said.

No group has yet claimed responsibility for the attack, but Zabihullah Mujahid, a spokesman for the Afghan Taliban, said the militant group was not involved in the shooting.

“The Afghan government strongly condemns the heinous and cowardly attack on Afghans’ greatest friend, Dr. Nakamura,” said Sediq Sediqqi, a spokesman for Afghan president Ashraf Ghani. “[He] has dedicated all his life to change the lives of Afghans.”

Our Morning Update and Evening Update newsletters are written by Globe editors, giving you a concise summary of the day’s most important headlines. Sign up today.

Report an error
Due to technical reasons, we have temporarily removed commenting from our articles. We hope to have this fixed soon. Thank you for your patience. If you are looking to give feedback on our new site, please send it along to feedback@globeandmail.com. If you want to write a letter to the editor, please forward to letters@globeandmail.com.

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff. Non-subscribers can read and sort comments but will not be able to engage with them in any way. Click here to subscribe.

If you would like to write a letter to the editor, please forward it to letters@globeandmail.com. Readers can also interact with The Globe on Facebook and Twitter .

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff. Non-subscribers can read and sort comments but will not be able to engage with them in any way. Click here to subscribe.

If you would like to write a letter to the editor, please forward it to letters@globeandmail.com. Readers can also interact with The Globe on Facebook and Twitter .

Welcome to The Globe and Mail’s comment community. This is a space where subscribers can engage with each other and Globe staff.

We aim to create a safe and valuable space for discussion and debate. That means:

  • Treat others as you wish to be treated
  • Criticize ideas, not people
  • Stay on topic
  • Avoid the use of toxic and offensive language
  • Flag bad behaviour

Comments that violate our community guidelines will be removed.

Read our community guidelines here

Discussion loading ...

Cannabis pro newsletter
To view this site properly, enable cookies in your browser. Read our privacy policy to learn more.
How to enable cookies